AACR Annual Meeting

Apr 23, 08 NEW STORY 09:00 ET Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research   Apr 18, 08 11:48 ET FASgen, Inc. Presents Ovarian Cancer Efficacy and Toxicology Data to the American Association for Cancer Research   Apr 17, 08 16:05 ET Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research   Apr 16, 08 18:00 ET NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect   17:05 ET SuperGen Identifies Lead PIM Kinase Inhibitor, SGI-1776, That Causes Tumor Regression in AML Xenograft Models   16:09 ET Kosan Presents Preclinical Data on Novel Third-Generation Hsp90 Inhibitors at AACR   16:06 ET Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR   16:00 ET Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting   11:00 ET Pharmacyclics' Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer   08:30 ET Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research   08:00 ET Medarex Reports Preclinical Data on Multiple Antibody-Drug Conjugate Candidates at American Association for Cancer Research Meeting   07:00 ET EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting      Apr 15, 08 16:00 ET SGX Presents Preclinical MET Data at AACR   12:24 ET Access Pharmaceuticals Presents New Data on ProLindac(TM) at the AACR Annual Meeting   11:00 ET Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting   11:00 ET Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors   08:45 ET Preclinical Study Presented at AACR Annual Meeting Shows Peregrine's Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model   08:00 ET Data Show SuperGen's MP-470 is Safe in Humans   08:00 ET Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference   07:45 ET Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer   07:00 ET Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting   06:00 ET ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study   Apr 14, 08 16:00 ET SuperGen's DNA Methyltransferase Inhibitor, S-110, Improves In Vivo Efficacy Profile of Decitabine   15:00 ET Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies   15:00 ET Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma   15:00 ET Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study   08:30 ET Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment   08:30 ET Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models   08:00 ET SuperGen's MP-470 Sensitizes Prostate and Breast Cancer Cells to Erlotinib   07:00 ET EntreMed's Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session      05:00 ET BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies   01:46 ET PG500 Series Presented at the AACR Annual Meeting in San Diego   Apr 13, 08 11:00 ET Poniard Pharmaceuticals' Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial   Apr 11, 08 08:00 ET ABR-Affinity BioReagents to Participate in the American Association for Cancer Research Meeting in San Diego, California, April 12 - 16, 2008   08:00 ET Peregrine Pharmaceuticals Announces Four Upcoming Presentations at the American Association for Cancer Research 2008 Annual Meeting   07:00 ET EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting      Apr 10, 08 12:38 ET Access Pharmaceuticals to Present New Data on ProLindac(TM) at the AACR Annual Meeting 2008 Conference   08:30 ET BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer   Apr 07, 08 16:05 ET Telik Announces Preclinical Presentations at AACR Annual Meeting   08:00 ET Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences   08:00 ET Specialized Genasense(R) Clinical Trials Featured at AACR Meeting   08:00 ET SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting   07:45 ET Accuri Cytometers Announces Commercial Launch of Revolutionary Accuri C6 Flow Cytometer(TM) System   Apr 03, 08 07:30 ET Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting   Mar 20, 08 15:13 ET DyCE(TM) (Dynamic Contrast Enhancement) Technology Now Part of CRi's Analysis Software Suite for the Popular Maestro(TM) in vivo Molecular Imaging System   Mar 18, 08 07:00 ET Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research   Mar 17, 08 07:00 ET Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research